{"url":"https://lda.senate.gov/api/v1/filings/a85d6fc4-a73c-46a2-a1cb-2e01ce8c8a87/?format=json","filing_uuid":"a85d6fc4-a73c-46a2-a1cb-2e01ce8c8a87","filing_type":"RR","filing_type_display":"Registration","filing_year":2020,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a85d6fc4-a73c-46a2-a1cb-2e01ce8c8a87/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Minor, Partner","dt_posted":"2020-07-21T17:44:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 8th Street, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":76855,"url":"https://lda.senate.gov/api/v1/registrants/76855/?format=json","house_registrant_id":32113,"name":"DLA PIPER LLP (US)","description":"Law firm.","address_1":"500 8th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM MINOR","contact_telephone":"+1 202-799-4312","dt_updated":"2026-01-29T14:20:14.358284-05:00"},"client":{"id":206375,"url":"https://lda.senate.gov/api/v1/clients/206375/?format=json","client_id":1006640,"name":"10X GENOMICS, INC.","general_description":"Life science technology company.","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-06-04"},"lobbying_activities":[{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax issues associated with COVID-19 relief, including the research and development tax credit.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":27642,"prefix":"mr","prefix_display":"MR.","first_name":"EVAN","nickname":null,"middle_name":"M","last_name":"MIGDAIL","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":65706,"prefix":null,"prefix_display":null,"first_name":"MELISSA","nickname":null,"middle_name":null,"last_name":"GIERACH","suffix":null,"suffix_display":null},"covered_position":"Senior Policy Advisor, Rep. Charles Boustany; Senior Policy Advisor, Rep. Dennis Ross; Senior Policy Advisor, Rep. John Sullivan; Legislative Assistant, Rep. Cliff Stearns; Legislative Correspondent, Rep. Dana Rohrabacher","new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}